Featured article: The expansion of targetable biomarkers for CAR T cell therapy
Biomarkers are an integral part of cancer management due to their use in risk assessment, screening, differential diagnosis, prognosis, prediction of response to treatment, and monitoring progress of disease. In this review, Michelle Townsend et al. discuss the biomarkers currently under investigation and point out several promising biomarkers in the preclinical stage of development that may be useful as targets.
Click here to access the full article.
Click here to access all of the reviews published to date in Journal of Experimental & Clinical Cancer Research.
Click here to access the full article.
Click here to access all of the reviews published to date in Journal of Experimental & Clinical Cancer Research.
No hay comentarios:
Publicar un comentario